Zacks Research lowered its rating on Aehr Test Systems from strong-buy to hold. This change reflects a revised outlook on the semiconductor testing company's near-term performance.
The broader analyst consensus for AEHR remains a Moderate Buy. The average price target for the stock stands at $132.50.
Shares opened at $81.58 on the day of the announcement. Institutional investors currently hold 69.69% of the company's stock.